Cargando…

A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin

Amorphous solid dispersions (ASDs) based on proteins as co-formers have previously shown promising potential to improve the solubility and bioavailability of poorly water-soluble drugs. In particular, whey proteins have shown to be promising co-formers and amorphous stabilizers in ASD formulations,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Xuezhi, Margrethe Brekstad Kjellin, Maud, Schaal, Zarah, Zhang, Tengyu, Löbmann, Korbinian, Leng, Donglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865404/ https://www.ncbi.nlm.nih.gov/pubmed/36678757 http://dx.doi.org/10.3390/pharmaceutics15010126

Ejemplares similares

Stabilizing Mechanisms of β-Lactoglobulin in Amorphous Solid Dispersions of Indomethacin
por: Kabedev, Aleksei, et al.
Publicado: (2022)

The Influence of Pressure on the Intrinsic Dissolution Rate of Amorphous Indomethacin
por: Löbmann, Korbinian, et al.
Publicado: (2014)

Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying
por: Craye, Goedele, et al.
Publicado: (2015)

Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations
por: Mishra, Jaya, et al.
Publicado: (2018)

Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies
por: Liu, Jingwen, et al.
Publicado: (2021)

Enabling formulations of aprepitant: in vitro and in vivo comparison of nanocrystalline, amorphous and deep eutectic solvent based formulations
por: Palmelund, Henrik, et al.
Publicado: (2021)

Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
por: Jensen, Katrine Tarp, et al.
Publicado: (2014)

Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations
por: Kasten, Georgia, et al.
Publicado: (2019)

Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation
por: Long, Chiau Ming, et al.
Publicado: (2019)

Highly Polymorphic Materials and Dissolution Behaviour: The Peculiar Case of Rifaximin
por: Bianchera, Annalisa, et al.
Publicado: (2022)

Microwave-Induced In Situ Amorphization: A New Strategy for Tackling the Stability Issue of Amorphous Solid Dispersions
por: Qiang, Wei, et al.
Publicado: (2020)

Studying the Impact of the Temperature and Sorbed Water during Microwave-Induced In Situ Amorphization: A Case Study of Celecoxib and Polyvinylpyrrolidone
por: Hempel, Nele-Johanna, et al.
Publicado: (2021)

Hot Melt Coating of Amorphous Carvedilol
por: Bannow, Jacob, et al.
Publicado: (2020)

Impact of drug loading in mesoporous silica-amorphous formulations on the physical stability of drugs with high recrystallization tendency
por: Antonino, Rayane S.C.M.Q., et al.
Publicado: (2019)

Direct Measurement of Amorphous Solubility
por: Štukelj, Jernej, et al.
Publicado: (2019)

Impact of Simulated Intestinal Fluids on Dissolution, Solution Chemistry, and Membrane Transport of Amorphous Multidrug Formulations
por: El Sayed, Mira, et al.
Publicado: (2021)

Convection-Induced vs. Microwave Radiation-Induced in situ Drug Amorphization
por: Hempel, Nele-Johanna, et al.
Publicado: (2020)

Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin
por: Beyer, Andreas, et al.
Publicado: (2015)

Influence of the Polymer Glass Transition Temperature and Molecular Weight on Drug Amorphization Kinetics Using Ball Milling
por: Asgreen, Camilla, et al.
Publicado: (2020)

Mineral dissolution and reprecipitation mediated by an amorphous phase
por: Konrad-Schmolke, Matthias, et al.
Publicado: (2018)

The Influence of Temperature and Viscosity of Polyethylene Glycol on the Rate of Microwave-Induced In Situ Amorphization of Celecoxib
por: Hempel, Nele-Johanna, et al.
Publicado: (2020)

Special issue on “Formulation strategies and manufacturing technologies to enhance non-invasive drug delivery”
por: Löbmann, Korbinian, et al.
Publicado: (2018)

Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
por: Jara, Miguel O., et al.
Publicado: (2022)

Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms
por: Ansari, Shaquib Rahman, et al.
Publicado: (2022)

Amorphous-Amorphous Phase Separation in API/Polymer Formulations
por: Luebbert, Christian, et al.
Publicado: (2017)

Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study
por: Jara, Miguel O., et al.
Publicado: (2021)

The Effect of the Molecular Weight of Polyvinylpyrrolidone and the Model Drug on Laser-Induced In Situ Amorphization
por: Hempel, Nele-Johanna, et al.
Publicado: (2021)

The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles
por: Hempel, Nele-Johanna, et al.
Publicado: (2021)

Synthesis and characterization of amorphous precipitated silica from alkaline dissolution of olivine
por: Raza, Nadeem, et al.
Publicado: (2018)

Image-based dissolution analysis for tracking the surface stability of amorphous powders
por: Štukelj, Jernej, et al.
Publicado: (2020)

Dissolution and pharmacokinetics of a novel micronized aspirin formulation
por: Voelker, M., et al.
Publicado: (2011)

Dissolution enhancement of albendazole through nanocrystal formulation
por: Koradia, D. Krishna, et al.
Publicado: (2012)

Assessment of Dissolution Profile of Marketed Aceclofenac Formulations
por: Soni, T, et al.
Publicado: (2010)

In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
por: Bermejo, Marival, et al.
Publicado: (2020)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions
por: Monschke, Marius, et al.
Publicado: (2020)

Dissolution of Amorphous S53P4 Glass Scaffolds in Dynamic In Vitro Conditions
por: Aalto-Setälä, Laura, et al.
Publicado: (2021)

Correction: Synthesis and characterization of amorphous precipitated silica from alkaline dissolution of olivine
por: Raza, Nadeem, et al.
Publicado: (2018)

Nanoseeded Desupersaturation and Dissolution Tests for Elucidating Supersaturation Maintenance in Amorphous Solid Dispersions
por: Guner, Gulenay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ad42ffval0fqcq8g5qd1sn00r6